Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04498117
Title Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors OncoQuest Pharmaceuticals Inc.
Indications

endometrioid ovary carcinoma

fallopian tube adenocarcinoma

ovarian clear cell adenocarcinoma

peritoneal carcinoma

ovary adenocarcinoma

ovarian carcinoma

ovary serous adenocarcinoma

Therapies

Carboplatin + Oregovomab + Paclitaxel

Carboplatin + Paclitaxel

Age Groups: adult senior


No variant requirements are available.